Tiffany earned her PhD in Genetics from North Carolina State University, where she explored the effect of genetic background on the ability to derive induced pluripotent stem cells. She completed her postdoctoral training at the University of North Carolina at Chapel Hill, specializing in the development of translational approaches to direct cardiac reprogramming and understanding the mechanisms of cardiomyocyte maturation. She has written for multiple medical, nonprofit, and academic peer-reviewed outlets. In March 2020, Tiffany joined LabX Media Group as an assistant science editor for The Scientist. She began working with Drug Discovery News in October 2020.
In the 1930s, HPV
wasn’t on the radar for most scientists.Four decades passed before anyone connected
HPV with cervical, penile, or anal cancer, and it took even longer before scientists
developed a prophylactic vaccine.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.